This partnership merges BioSkryb's single cell amplification and multi-omics chemistry with 1Cell.Ai's OncoIncytes platform, creating a groundbreaking solution for analyzing rare cell populations such ...

This important study, which tackles the challenge of analyzing genome integrity and instability in unicellular pathogens by introducing a novel single-cell genomics approach, presents compelling ...